KD Logo

TNYA stock rated an Outperform by William Blair

In a filing, Tenaya Therapeutics Inc revealed its SVP, Finance Higa Tomohiro unloaded Company’s shares for reported $1336.0 on Mar 10 ’25. In the deal valued at $0.54 per share,2,482 shares were sold. As a result of this transaction, Higa Tomohiro now holds 99,690 shares worth roughly $69783.0.

Then, Tingley Whittemore sold 7,398 shares, generating $3,983 in total proceeds. Upon selling the shares at $0.54, the Chief Medical Officer now owns 174,793 shares.

Before that, Ali Faraz sold 9,741 shares. Tenaya Therapeutics Inc shares valued at $5,245 were divested by the Chief Executive Officer at a price of $0.54 per share. As a result of the transaction, Ali Faraz now holds 320,514 shares, worth roughly $0.22 million.

William Blair initiated its Tenaya Therapeutics Inc [TNYA] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late November with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering TNYA with “Buy” recommendation on June 15, 2022.

Price Performance Review of TNYA

On Friday, Tenaya Therapeutics Inc [NASDAQ:TNYA] saw its stock jump 4.28% to $0.70. Over the last five days, the stock has gained 53.60%. Tenaya Therapeutics Inc shares have fallen nearly -51.13% since the year began. Nevertheless, the stocks have fallen -87.41% over the past one year. While a 52-week high of $5.39 was reached on 01/07/25, a 52-week low of $0.39 was recorded on 03/04/25. SMA at 50 days reached $1.0664, while 200 days put it at $2.2857.

Levels Of Support And Resistance For TNYA Stock

The 24-hour chart illustrates a support level at 0.6566, which if violated will result in even more drops to 0.6142. On the upside, there is a resistance level at 0.7401. A further resistance level may holdings at 0.7812. The Relative Strength Index (RSI) on the 14-day chart is 40.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0458, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.20%. Stochastics %K at 35.15% indicates the stock is a holding.

How much short interest is there in Tenaya Therapeutics Inc?

A steep rise in short interest was recorded in Tenaya Therapeutics Inc stocks on 2025-02-28, growing by 2.15 million shares to a total of 14.4 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 12.24 million shares. There was a rise of 14.96%, which implies that there is a positive sentiment for the stock.

Most Popular